Insulin-Like Growth Factor-I Induces Arginase Activity in Leishmania amazonensis Amastigote-Infected Macrophages through a Cytokine-Independent Mechanism

Mediators of Inflammation

Volumn 2014, Issue , 2015, Pages

  Vendrame, Celia Maria Vieira ^a   Carvalho, Marcia Dias Teixeira ^a   Tempone, Andre Gustavo ^b   Goto, Hiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CYTOKINE; LIPOSOME; PHOSPHATIDYLSERINE; SOMATOMEDIN C;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; LEISHMANIA; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; BAGG ALBINO MOUSE; ENZYMOLOGY; MACROPHAGE; METABOLISM; PARASITOLOGY; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

LEISHMANIA AMAZONENSIS;

ANIMALS; ARGINASE; BLOTTING, WESTERN; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; INSULIN-LIKE GROWTH FACTOR I; LEISHMANIA; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C;

EID: 84930950367     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/475919     Document Type: Article

References (53)

1. P. Desjeux, "Leishmaniasis: current situation and new perspectives", Comparative Immunology, Microbiology and Infectious Diseases, vol. 27, no. 5, pp. 305-318, 2004.
2. H. Goto and J. A. Lauletta Lindoso, "Cutaneous and mucocutaneous leishmaniasis", Infectious Disease Clinics of North America, vol. 26, no. 2, pp. 293-307, 2012.
3. A. C. Cunningham, "Parasitic adaptivemechanisms in infection by Leishmania", Experimental and Molecular Pathology, vol. 72, no. 2, pp. 132-141, 2002.
4. A. M. Da-Cruz, R. Bittar, M. Mattos et al., "T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy", Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 2, pp. 251-256, 2002.
5. F. T. Silveira, R. Lainson, C. M. De Castro Gomes, M. D. Laurenti, and C. E. P. Corbett, "Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis", Parasite Immunology, vol. 31, no. 8, pp. 423-431, 2009.
6. L. P. Carvalho, S. Passos, O. Bacellar et al., "Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis", Parasite Immunology, vol. 29, no. 5, pp. 251-258, 2007.
7. D. R. Faria, K. J. Gollob, J. Barbosa Jr. et al., "Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis", Infection and Immunity, vol. 73, no. 12, pp. 7853-7859, 2005.
8. A. B. B. Macedo, J. C. Sánchez-Arcila, A. O. Schubach et al., "Multifunctional CD4+T cells in patients with American cutaneous leishmaniasis", Clinical and Experimental Immunology, vol. 167, no. 3, pp. 505-513, 2012.
9. W. J. Beil, G. Meinardus-Hager, D.-C. Neugebauer, and C. Sorg, "Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice", Journal of Leukocyte Biology, vol. 52, no. 2, pp. 135-142, 1992.
10. F. J. S. Rocha, U. Schleicher, J. Mattner, G. Alber, and C. Bogdan, "Cytokines, signaling pathways, and effectormolecules required for the control of Leishmania (Viannia) braziliensis in mice", Infection and Immunity, vol. 75, no. 8, pp. 3823-3832, 2007.
11. B. A. S. Pereira and C. R. Alves, "Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis", Veterinary Parasitology, vol. 158, no. 4, pp. 239-255, 2008.
12. L. C. C. Afonso and P. Scott, "Immune responses associatedwith susceptibility of C57BL/10 mice to Leishmania amazonensis", Infection and Immunity, vol. 61, no. 7, pp. 2952-2959, 1993.
13. L. Soong, C.-H. Chang, J. Sun et al., "Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection", Journal of Immunology, vol. 158, no. 11, pp. 5374-5383, 1997.
14. H. Qi, J. Ji, N. Wanasen, and L. Soong, "Enhanced replication of Leishmania amazonensis amastigotes in gamma interferonstimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis", Infection and Immunity, vol. 72, no. 2, pp. 988-995, 2004.
15. L. Soong, "Subversion and utilization of host innate defense by Leishmania amazonensis", Frontiers in Immunology, vol. 3, article 58, 2012.
16. J. I. Jones and D. R. Clemmons, "Insulin-like growth factors and their binding proteins: biological actions", Endocrine Reviews, vol. 16, no. 1, pp. 3-34, 1995.
17. S. Arkins, N. Rebeiz, D. L. Brunke-Reese, A. Biragyn, and K. W. Kelley, "Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level", Molecular Endocrinology, vol. 9, no. 3, pp. 350-360, 1995.
18. M. W. Wynes and D. W. H. Riches, "Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13", Journal of Immunology, vol. 171, no. 7, pp. 3550-3559, 2003.
19. H. Goto, C. M. C. Gomes, C. E. P. Corbett, H. P. Monteiro, and M. Gidlund, "Insulin-like growth factor I is a growth-promoting factor for Leishmania promastigotes and amastigotes", Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 13211-13216, 1998.
20. C. M. C. Gomes, H. Goto, C. E. P. Corbett, and M. Gidlund, "Insulin-like growth factor-1 is a growth promoting factor for Leishmania promastigotes", Acta Tropica, vol. 64, no. 3-4, pp. 225-228, 1997.
21. C. M. D. C. Gomes, H. Goto, V. L. Ribeiro Da Matta, M. D. Laurenti, M. Gidlund, and C. E. P. Corbett, "Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis", International Journal of Experimental Pathology, vol. 81, no. 4, pp. 249-255, 2000.
22. U. A. Wenzel, E. Bank, C. Florian et al., "Leishmania major parasite stage-dependent host cell invasion and immune evasion", The FASEB Journal, vol. 26, no. 1, pp. 29-39, 2012.
23. Y. Wang, Y. Chen, L. Xin et al., "Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes", Infection and Immunity, vol. 79, no. 3, pp. 1124-1133, 2011.
24. C. M. C. Gomes, H. P. Monteiro, M. Gidlund, C. E. P. Corbett, and H. Goto, "Insulin-like growth factor-I induces phosphorylation in Leishmania (Leishmania) mexicana promastigotes and amastigotes", Journal of Eukaryotic Microbiology, vol. 45, no. 3, pp. 352-355, 1998.
25. C. M. V. Vendrame, M. D. T. Carvalho, F. J. O. Rios, E. R. Manuli, F. Petitto-Assis, and H. Goto, "Effect of insulinlike growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro", Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 287-296, 2007.
26. F. O. Martinez and S. Gordon, "The M1 and M2 paradigm of macrophage activation: time for reassessment", F1000Prime Rep, 2014.
27. J. M. De Freitas Balanco, M. E. Costa Moreira, A. Bonomo et al., "Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity", Current Biology, vol. 11, no. 23, pp. 1870-1873, 2001.
28. A. Tripathi and C. M. Gupta, "Transbilayer translocation of membrane phosphatidylserine and its role in macrophage invasion in Leishmania promastigotes", Molecular and Biochemical Parasitology, vol. 128, no. 1, pp. 1-9, 2003.
29. J. França-Costa, J. L. M. Wanderley, P. Deolindo et al., "Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity", PloS one, vol. 7, no. 5, Article ID e36595, 2012.
30. V. Iniesta, L. C. Gómez-Nieto, and I. Corraliza, "The inhibition of arginase by N (omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages", Journal of Experimental Medicine, vol. 193, no. 6, pp. 777-784, 2001.
31. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurement with the folin phenol reagent", The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
32. I. M. Corraliza, M. L. Campo, G. Soler, and M. Modolell, "Determination of arginase activity in macrophages: a micromethod", Journal of ImmunologicalMethods, vol. 174, no. 1-2, pp. 231-235, 1994.
33. L. C. Green, D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum, "Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids", Analytical Biochemistry, vol. 126, no. 1, pp. 131-138, 1982.
34. E. Pick and Y. Keisari, "A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture", Journal of Immunological Methods, vol. 38, no. 1-2, pp. 161-170, 1980.
35. M. Das, S. B. Mukherjee, and C. Shaha, "Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes", Journal of Cell Science, vol. 114, no. 13, pp. 2461-2469, 2001.
36. A. G. Tempone, R. A. Mortara, H. F. De Andrade, and J. Q. Reimão, "Therapeutic evaluation of free and liposomeloaded furazolidone in experimental visceral leishmaniasis", International Journal of Antimicrobial Agents, vol. 36, no. 2, pp. 159-163, 2010.
37. A. G. Tempone, D. Perez, S. Rath, A. L. Vilarinho, R. A. Mortara, and H. F. De Andrade Jr., "Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine", Journal of Antimicrobial Chemotherapy, vol. 54, no. 1, pp. 60-68, 2004.
38. V. Iniesta, L. C. Gómez-Nieto, I. Molano et al., "Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites", Parasite Immunology, vol. 24, no. 3, pp. 113-118, 2002.
39. C. Bogdan, M. Rollinghoff, and A. Diefenbach, "Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity", Current Opinion in Immunology, vol. 12, no. 1, pp. 64-76, 2000.
40. R. M. Mukbel, C. Patten Jr., K. Gibson, M. Ghosh, C. Petersen, and D. E. Jones, "Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide", The American Journal of Tropical Medicine and Hygiene, vol. 76, no. 4, pp. 669-675, 2007.
41. S. C. Roberts, M. J. Tancer, M. R. Polinsky, K. Michael Gibson, O. Heby, and B. Ullman, "Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania: characterization of gene deletion mutants", The Journal of Biological Chemistry, vol. 279, no. 22, pp. 23668-23678, 2004.
42. H. M. Muleme, R. M. Reguera, A. Berard et al., "Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis", Journal of Immunology, vol. 183, no. 12, pp. 8068-8076, 2009.
43. P. K. Ramos, V. Brito Mde, F. T. Silveira et al., "In vitro cytokines profile and ultrastructural changes of microglia and macrophages following interaction with Leishmania", Parasitology, vol. 141, no. 8, pp. 1052-1063, 2014.
44. M. Munder, M. Mallo, K. Eichmann, and M. Modolell, "Murine macrophages secrete interferon γ upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation", Journal of Experimental Medicine, vol. 187, no. 12, pp. 2103-2108, 1998.
45. N. E. Reiner, W. Ng, C. B. Wilson, W. R. McMaster, and S. K. Burchett, "Modulation of in vitro monocyte cytokine responses to Leishmania donovani: interferon-γ prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-γ and interleukin 1", Journal of Clinical Investigation, vol. 85, no. 6, pp. 1914-1924, 1990.
46. S. Buates and G. Matlashewski, "General suppression of macrophage gene expression during Leishmania donovani infection", Journal of Immunology, vol. 166, no. 5, pp. 3416-3422, 2001.
47. D. A. Rappolee, D. Mark, M. J. Banda, and Z. Werb, "Wound macrophages express TGF-αand other growth factors in vivo: analysis by mRNA phenotyping", Science, vol. 241, no. 4866, pp. 708-712, 1988.
48. L. C. Reis, E. M. Ramos-Sanchez, and H. Goto, "The interactions and essential effects of intrinsic insulin-like growth factor-I on Leishmania (Leishmania) major growth within macrophages", Parasite Immunology, vol. 35, no. 7-8, pp. 239-244, 2013.
49. A. Weingärtner, G. Kemmer, F. D. Müller et al., "Leishmania promastigotes lack phosphatidylserine but bind annexin V upon permeabilization or miltefosine treatment", PLoS ONE, vol. 7, no. 8, Article ID e42070, 2012.
50. Y. Aramaki, R. Matsuno, and S. Tsuchiya, "Involvement of p38 MAP kinase in the inhibitory effects of phosphatidylserine liposomes on nitric oxide production from macrophages stimulated with LPS", Biochemical and Biophysical Research Communications, vol. 280, no. 4, pp. 982-987, 2001.
51. E. Cama, F. A. Emig, D. E. Ash, and D. W. Christianson, "Structural and functional importance of first-shell metal ligands in the binuclearmanganese cluster of arginase I", Biochemistry, vol. 42, no. 25, pp. 7748-7758, 2003.
52. F. L. Ribeiro-Gomes, A. C. Otero, N. A. Gomes et al., "Macrophage interactions with neutrophils regulate Leishmania major infection", Journal of Immunology, vol. 172, no. 7, pp. 4454-4462, 2004.
53. L. Afonso, V. M. Borges, H. Cruz et al., "Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis", Journal of Leukocyte Biology, vol. 84, no. 2, pp. 389-396, 2008